These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34224536)

  • 21. Establishment of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Immunosuppressant Levels in the Peripheral Blood Mononuclear Cells of Chinese Renal Transplant Recipients.
    Chen B; Lu JQ; Shao K; Zhai XH; An HM; Shi HQ; Zhou PJ
    Ther Drug Monit; 2020 Oct; 42(5):686-694. PubMed ID: 32858576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
    Lemaitre F; Antignac M; Fernandez C
    Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts.
    Miura M; Higashiyama H; Fukasawa Y; Itoh Y; Tamaki T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():58-60. PubMed ID: 26031588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
    Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
    Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples.
    Bittersohl H; Schniedewind B; Christians U; Luppa PB
    J Chromatogr A; 2018 Apr; 1547():45-52. PubMed ID: 29544893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
    Transplant Proc; 2019 Jun; 51(5):1424-1427. PubMed ID: 31060742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients.
    Vethe NT; Gustavsen MT; Midtvedt K; Lauritsen ME; Andersen AM; Åsberg A; Bergan S
    Ther Drug Monit; 2019 Oct; 41(5):607-614. PubMed ID: 31584926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center.
    Ciancio G; Tryphonopoulos P; Gaynor JJ; Guerra G; Sageshima J; Roth D; Chen L; Kupin W; Mattiazzi A; Tueros L; Flores S; Hanson L; Powell RH; Ruiz P; Vianna R; Burke GW
    Transplant Proc; 2016; 48(6):2006-10. PubMed ID: 27569936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies.
    Md Dom ZI; Noll BD; Coller JK; Somogyi AA; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():171-7. PubMed ID: 24342510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients.
    Niioka T; Kagaya H; Saito M; Inoue T; Numakura K; Yamamoto R; Akamine Y; Habuchi T; Satoh S; Miura M
    Int J Urol; 2016 Jun; 23(6):484-90. PubMed ID: 26990259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution evaluation of tacrolimus in the ascitic fluid of liver transplant recipients with liver cirrhosis by a sensitive ultra-performance liquid chromatography-tandem mass spectrometry method.
    Yang N; Du Y; He J; Ge J; Wang M; Sun R; Zhu H; Ge W
    J Sep Sci; 2022 Jan; 45(2):411-421. PubMed ID: 34694679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients.
    Santos T; Santos L; Macário F; Romãozinho C; Alves R; Campos M; Mota A
    Transplant Proc; 2015 May; 47(4):906-10. PubMed ID: 26036483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients.
    Tron C; Rayar M; Petitcollin A; Beaurepaire JM; Cusumano C; Verdier MC; Houssel-Debry P; Camus C; Boudjema K; Bellissant E; Lemaitre F
    J Chromatogr A; 2016 Dec; 1475():55-63. PubMed ID: 27837999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.